Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UMC Utrecht
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individual is scheduled to undergo renal denervation as standard patient care for resistant hypertension.
Individual is diagnosed with resistant hypertension. Secondary causes and a white coat hypertension are actively excluded.
Individual is ≥18 years of age.
Individual agrees to have all study procedures performed, and is competent and willing to provide written informed consent to participate in this clinical study.
You may not be if
Individual is excluded from treatment with pRDN .
Individual has an estimated glomerular filtration rate (eGFR) of \<30mL/min/1.73m2, using the MDRD calculation.
Individual has experienced a myocardial infarction, unstable angina pectoris, or a cerebrovascular accident within 6 months of the screening visit, or has widespread atherosclerosis, with documented intravascular thrombosis or unstable plaques.
Individual has any serious medical condition, which in the opinion of the investigator, may adversely affect the safety and/or effectiveness of the participant or the study (i.e., patients with clinically significant peripheral vascular disease, abdominal aortic aneurysm, bleeding disorders such as thrombocytopenia, haemophilia or significant anaemia).
Individual is pregnant, nursing or planning to be pregnant.
Individual has a known, unresolved history of drug use or alcohol dependency, lacks the ability to comprehend or follow instructions, or would be unlikely or unable to comply with study follow-up requirements.
Clareo Health | The Effect of Renal Denervation on Renal Flow in Humans
